John J. Harrington, Chief Scientific Officer at ATHERSYS, INC / NEW (ATHX), sold 23,769 shares at $1.42 ($34K) on 2014-09-19, disclosed to the SEC on 2014-09-22.
Scheduled sale ($34k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 4,050 | $6K | 16.7% |
| 2 | $1.44 | 15,619 | $22K | 66.2% |
| 3 | $1.42 | 4,100 | $6K | 17.1% |
| Total | $1.43 avg | 23,769 | $34K | 100% |
| Filing → |
| ATHX | SELL | 2021-06-08 | $47K | — | Filing → |
| ATHX | SELL | 2021-06-02 | $36K | — | Filing → |
| ATHX | SELL | 2021-03-17 | $20K | — | Filing → |